BABurak Mert Akhan

Burak Mert Akhan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Burak Mert Akhan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Endovascular management of vascular complications in hemodialysis patients: a single-center experience

    by Ati̇yE Cenay Karabörk Kiliç, Burak Mert Akhan, Nemat Ibrahi̇mKhanli, Esra Kulaksiz Turan, Fati̇h Öncü, Mehmet Koray Akkan, Ahmet Baran Onal, Erhan Turgut Ilgit

    Background/aim: Vascular access failure remains a major cause of morbidity in patients undergoing hemodialysis. This study aimed to evaluate the types of endovascular interventions performed for hemodialysis-related vascular complications, as well as their technical success and patency outcomes, at a single center. Materials and methods: A total of 103 lesions in 89 patients treated between 2001 and 2023 were retrospectively analyzed. Catheterrelated complications, central venous stenosis or occlusion, and arteriovenous fistula- or graft-related complications were managed using endovascular techniques. Endovascular interventions included catheter repositioning, thrombolysis, percutaneous transluminal angioplasty (PTA), stent placement for central venous lesions, PTA of the fistula vein or feeding artery, and fistula closure. Adjunctive antiplatelet therapy was used selectively, particularly after stent placement. Primary patency rates were assessed at 6 and 12 months in patients with available follow-up data. Descriptive statistics were performed. Results: Of the lesions analyzed, 22% were catheter-related, 51% involved central venous stenosis or occlusion, and 26% were accessrelated. Technical success was achieved in 100% of catheter repositioning cases. The success rate for thrombolysis of occluded catheters was 80%. PTA for central venous lesions had an 86% success rate, while stenting had a 100% success rate. Follow-up data for patency assessment were available in 34 patients. Among patients with available follow-up data, the primary patency rates at 6 and 12 months for central venous lesions treated with PTA were 85% and 70%, respectively. When PTA was combined with stenting in these lesions, primary patency rates at 6 and 12 months were 55% and 33%, respectively. In patients with juxta-anastomotic vein stenosis of an arteriovenous fistula, PTA achieved a 6-month primary patency rate of 60%; however, 12-month follow-up data were unavailable. Fistula closure was technically successful in the single patient who required this procedure. Conclusion: In this single-center retrospective study, endovascular interventions were associated with high immediate technical success in hemodialysis patients with vascular access-related complications. However, patency outcomes should be interpreted cautiously because follow-up data were available only for a subgroup of patients. PTA and selective stent placement may represent useful minimally invasive treatment options for maintaining or restoring vascular access function.

  • Open Access

    Bronchial Artery Embolization for Massive Hemoptysis: Single-Center Experience

    by Fatih Öncü, Nezih Yaylı, Burak Mert Akhan, Koray Akkan, Baran Önal, Erhan Ilgıt

    Objective: To evaluate the feasibility and safety of bronchial artery embolization (BAE) as a first-line endovascular treatment in patients presenting to the clinic with massive hemoptysis. Methods: In this retrospective single-center study, 43 patients (mean age: 55.6 ± 17.6 years) who underwent BAE for massive hemoptysis between 2016 and 2022 were analyzed. Patient demographics, indications, angiographic findings, embolization materials used, procedure success rates, recurrence rates (early and late), complications, and mortality rates were evaluated during a mean follow-up period of 24 months (range: 6-72 months). Results: Technical success was achieved in 97% of patients, while early clinical success was observed in 95.3%. Early recurrence occurred in 7.1% of cases and late recurrence in 16.2%. The most common etiologies in recurrent cases were recanalization and systemic collaterals. The complication rate was 18.6% and the most common complication was transient chest pain; 1 patient had transient paraplegia. The mortality rate was 7%. Conclusion: Bronchial artery embolization appears to be an effective and relatively safe intervention for the management of massive hemoptysis, demonstrating high technical and clinical success rates with acceptable complication and recurrence rates. Identification and management of non-bronchial systemic collaterals and selection of embolic agents on a case-by-case basis are important to minimize recurrence and improve long-term outcomes. Cite this article as: Öncü F, Yaylı N, Akhan BM, Akkan K, Önal B, Ilgıt E. Bronchial artery embolization for massive hemoptysis: single-center experience. Cerrahpaşa Med J. 2026, 50, 0073, doi: 10.5152/cjm.2026.25073.

  • Does Increased Echogenicity in the Caudothalamic Groove Always Indicate Hemorrhage in Early Infancy?

    by Merve Yazol, Burak Mert Akhan, Oznur Leman Boyunaga

    We aim to evaluate the diagnostic significance of caudothalamic groove (CTG) echogenicity on cranial ultrasonography (CUS) by examining its correlation with magnetic resonance imaging (MRI) findings, including susceptibility-weighted imaging (SWI). This retrospective study screened 131 neonatal intensive care unit neonatal intensive care unit infants with diagnostic-quality CUS and MRI (including SWI) performed between January 2019 and April 2022. Among these, 34 had CTG echogenicity on CUS; 18 of the 34 had no corresponding CTG hemorrhage on SWI and formed the analytic cohort. The final cohort included 18 infants (10 males, 8 females; mean gestational age 32.7 wk, range 25.3 to 39.3 wk). Five (27.8%) were term, 13 (72.2%) were preterm. Initial CUS demonstrating CTG echogenicity was performed at a mean of 15.7 postnatal days; echogenicity was bilateral in 9 (50%) and unilateral in 9 (50%), with teardrop-like morphology in 10 (55.6%). MRI with SWI was performed at a mean of 29 postnatal days (range 2 to 90 d). No hemorrhagic changes were observed in the CTG region on SWI. Three patients (16.7%) had normal MRI findings, 15 (83.3%) showed nonhemorrhagic abnormalities, including edema, thin corpus callosum, subependymal cysts, ventricular dilatation, or cortical malformations. This study demonstrates a discordance between CUS and SWI-MRI findings in infants with CTG echogenicity. The presence of term infants and bilateral involvement suggests that CTG echogenicity may be a nonspecific imaging finding that can reflect a variable pathophysiological process. Therefore, confirmatory MRI with SWI may be valuable for accurate diagnosis and clinical decision-making in both preterm and term neonates with isolated CTG echogenicity.


  • Open Access

    Treatment of Iatrogenic and Traumatic Vascular Lesions With Stent-Grafts

    by Fatih Öncü, Burak Mert Akhan, Abdullah Ozer, Koray Akkan, Baran Önal, Erhan T. Ilgit

    Aim: Purpose of this study is to report our experience with stent-graft applications in iatrogenic and traumatic vascular injuries. Methods: We report endovascular treatment of 65 patients (45 men, 20 women; age range 17 - 91 years-old, mean 60 ± 19 years), 65 iatrogenic and traumatic vascular lesions with stent-grafts. The localisations of the vascular lesions are as follows: 43 lower extremity, eight upper extremity, seven supra aortic, seven visceral. Early Doppler ultrasound imaging was performed before patient discharge. Results: Immediate technical success was achieved in 59 lesions (91%). In the remaining six lesions pathology continued and these cases were treated with accompanying embolisation (four with glue embolisation, one with vascular plug, one with concomitant stent-graft). Complications such as deformation or migration were not observed in any case. Follow-up was available for 53 lesions (mean follow-up 13 months, range 4-19 months). During the follow-up period, 13 cases of in-stent restenosis were observed. Seven cases of incomplete restenosis and two stent-graft occlusions were treated with balloon angioplasty, while one stent-graft occlusion was managed with the placement of an additional stent-graft. Three cases of in-stent restenosis were left untreated due to the absence of significant clinical symptoms. The primary patency rate was 76%, the primary assisted patency rate was 88%, and the secondary patency rate was 94%. Conclusions: Endovascular treatment of iatrogenic and traumatic vascular lesions with stent-grafts is a safe, effective and less invasive procedure.